Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Enterprise Value: 2010-2024

Historic Enterprise Value for Cryo Cell International (CCEL) over the last 15 years, with FY2024 value amounting to -$3.5 million.

  • Cryo Cell International's Enterprise Value fell 5146.23% to -$3.2 million in Q3 2025 from the same period last year, while for Aug 2025 it was -$3.2 million, marking a year-over-year decrease of 5146.23%. This contributed to the annual value of -$3.5 million for FY2024, which is 25665.83% down from last year.
  • Latest data reveals that Cryo Cell International reported Enterprise Value of -$3.5 million as of FY2024, which was down 25665.83% from -$980250.0 recorded in FY2023.
  • In the past 5 years, Cryo Cell International's Enterprise Value registered a high of -$713916.0 during FY2022, and its lowest value of -$10.4 million during FY2020.
  • For the 5-year period, Cryo Cell International's Enterprise Value averaged around -$4.8 million, with its median value being -$3.5 million (2024).
  • Its Enterprise Value has fluctuated over the past 5 years, first skyrocketed by 9143.83% in 2022, then tumbled by 25665.83% in 2024.
  • Annual analysis of 5 years shows Cryo Cell International's Enterprise Value stood at -$10.4 million in 2020, then increased by 20.2% to -$8.3 million in 2021, then soared by 91.44% to -$713916.0 in 2022, then plummeted by 37.31% to -$980250.0 in 2023, then tumbled by 256.66% to -$3.5 million in 2024.
  • Its Enterprise Value was -$3.5 million in FY2024, compared to -$980250.0 in FY2023 and -$713916.0 in FY2022.